TRIM13 and neoplasm: Furthermore, overexpression of TRIM13 in NSCLC has been shown to inactivate the NF-κB pathway, increase cleaved caspase-3 levels, inhibit tumor growth, and induce apoptosis in NSCLC cells (Xu et al. 2019).